Viimased lisandused - Proliferative Diabetic Retinopathy
|
vaatamisi: 4aug 20, 2026
|
|
vaatamisi: 6aug 20, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 736 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 836 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 736 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 536 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 736 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 536 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 536 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 1236 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 1236 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 836 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 636 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 836 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 836 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 736 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 636 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 636 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
PDR and Vitreous Hemorrhage with inadequate PRP (nonperfusion)vaatamisi: 136 year old with recent vision loss. Diabetes since age 8. Had light PRP done previously. VA 20/25, 20/80aug 17, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 37Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 36Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 31Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 19Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 17Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 18Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 21Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 11Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 15Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 16Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 20Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 18Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 16Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 13Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 16Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 20Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 24Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Neovacular Glaucoma from Proliferative Diabetic Retinopathyvaatamisi: 37Severe non-perfusion and NVG from PDRjuuli 21, 2026
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 215dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 198dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 211dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 164dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 172dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 143dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 163dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 174dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 142dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 157dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 145dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 183dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 175dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 138dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 184dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 143dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 145dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 127dets 23, 2024
|
|
Prethreshold PDR right eye - mild NVDvaatamisi: 160dets 23, 2024
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 22253 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 21653 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 22053 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 25853 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 25553 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 21653 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 25253 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 24453 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 20453 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 22553 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 22153 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 22253 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 22553 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 24453 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 20253 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 22753 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 21153 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 21153 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 21453 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 22953 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 21253 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 23153 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Proliferative diabetic retinopathy with vitreous hemorrhagevaatamisi: 24753 year old man with foggy vision in the left eye for one day. VA 20/25 OD, 20/40 OS. Diabetes for 10 years. Type IIsept 16, 2023
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 38729 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 37729 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 35329 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 39929 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 34529 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 36829 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 36429 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 32629 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 35329 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 33529 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 36629 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 38929 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 37529 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 32429 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 33629 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 37029 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 39229 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 34029 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 37929 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 32729 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
Pregnant - 25 weeks - new onset PDR and DME both eyes - Treated with PRP and ozurdexvaatamisi: 36829 year old female. Patient is 25 weeks pregnant and having flare up of retinopathy in both eyes. She states it is worse in the left. Patient has trouble with distant vision. At most recent visit, 1 years ago, VA was 20/20 OU. Two years ago anterior uveitis x 1 episode with normal labs (HLAB27, FTA, ACE, Lyme). 2017-2020 – Lucentis for DME left eye only.
PMHx: Type I DM since teenager, hyperlipidemia
BP was normalokt 19, 2021
|
|
|
|
